What are the latest figures on the radiotherapy devices market’s size and projected CAGR?
The radiotherapy devices market size has grown strongly in recent years. It will grow from $6.13 billion in 2024 to $6.71 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to growing incidence of cancer, patient-centric care, aging population, increasing awareness of radiotherapy devices, growing teletherapy and remote monitoring.
The radiotherapy devices market size is expected to see strong growth in the next few years. It will grow to $9.73 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to proton therapy expansion, immunotherapy combination, remote monitoring and teletherapy, growing demand for precise and targeted radiation treatments, minimally invasive radiotherapy techniques. Major trends in the forecast period include proton therapy advancements, hypofractionated radiotherapy, adaptive radiotherapy, patient experience enhancement, artificial intelligence (ai) integration.
Get Your Free Sample of The Global Radiotherapy Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3375&type=smp
Which Market drivers have played a significant role in driving the radiotherapy devices market?
The increasing cancer prevalence is expected to propel the growth of the radiotherapy devices market going forward. Cancer prevalence refers to the total number or percentage of individuals in a population who have been diagnosed with cancer at a particular point in time or over a specific period. Radiotherapy is commonly used as a primary or adjunctive treatment for cancer patients who have been newly diagnosed. It is often employed to shrink tumors, control cancer growth, or eliminate cancer cells before or after surgery. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. This upward trend highlights the growing prevalence of cancer within the country. Therefore, the increasing cancer prevalence is driving the growth of the radiotherapy devices market.
What are the key segments within the radiotherapy devices market?
The radiotherapy devices market covered in this report is segmented –
1) By Product Type: External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices
2) By Application: Skin Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Other Applications
3) By End Users: Hospitals, Ambulatory Surgical Centers, Oncological Treatment Centers
Subsegments:
1) By External Beam Radiation Therapy Devices: Intensity-Modulated Radiation Therapy (IMRT) Devices, Image-Guided Radiation Therapy (IGRT) Devices, Stereotactic Body Radiation Therapy (SBRT) Devices, Stereotactic Radiosurgery (SRS) Devices, 3D Conformal Radiation Therapy (3D CRT) Devices
2) By Linear Accelerator Devices: Conventional Linear Accelerators, Stereotactic Linear Accelerators
3) By Proton Therapy Devices: Cyclotron-Based Devices, Synchrotron-Based Devices, Synchrocyclotron-Based Devices
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report
Which key players are shaping the radiotherapy devices market?
Major companies operating in the radiotherapy devices market include Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Becton Dickinson and Company, IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Eckert & Ziegler Bebig, IsoRay Inc., General Electric Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corporation, Canon Medical Systems Corporation, AngioDynamics Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co. Ltd., Mevion Medical Systems Inc., Optivus Proton Therapy Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Provision Healthcare LLC, Sumitomo Heavy Industries Ltd., ViewRay Inc., Miranda Medical, Nordion Inc., NTP Radioisotopes SOC Ltd., Curium, Hitachi Ltd., Brainlab AG, Best Theratronics Ltd., ProTom International Inc., RefleXion Medical Inc., Insightec Ltd., HistoSonics Inc., Novocure Ltd., TomoTherapy Incorporated, Agile MV LLC, CIVCO Radiotherapy, Neutron Therapeutics, Diapulse Corporation of America, Johari Digital Healthcare Ltd., Alpha Tau Medical Ltd.
What are the top industry trends projected to impact the radiotherapy devices market?
Artificial Intelligence (AI) is a leading trend in the radiotherapy devices market and is gaining significant popularity in the market. The incorporation of AI innovation in disease care is expected to improve the exactness and speed of analysis, help clinical dynamics, and lead to better results. For instance, in October 2022, HCG cancer hospital launched AI-based radiation treatment technology for efficient radiotherapy. The traditional treatment arranging process takes days to make an improved radiation treatment conveyance plan, however, the new AI advancements are helping to speed up this procedure. AI is also expected to include deep learning applications in treatment planning, clinical decision support, automated image-guided adaptive radiation therapy, and genomic/radio-biologic data mining, thus supporting the growth of the market.
What are the major regional insights for the radiotherapy devices market, and which region holds the top position?
North America was the largest region in the radiotherapy devices market in 2023. Asia-Pacific was the second-largest region in the global radiotherapy devices market report. The regions covered in the radiotherapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Radiotherapy Devices Market Report 2025 Offer?
The radiotherapy devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Radiotherapy devices are used in cancer treatment by using high doses of radiation to kill cancer cells and shrink tumors. They are used to destroy cancerous cells and shrink tumors while minimizing damage to surrounding healthy tissue. By employing various techniques, such as external beam radiation and brachytherapy, these devices play a crucial role in cancer treatment and management.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3375
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
